Ambuja Cements Limited (LUX:AMCEM)

CTI BioPharma Ratios and Metrics

Market cap in millions EUR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	14,890	14,347	14,970	8,133	11,766	8,847
Market Cap Growth	-23.52%	-4.16%	84.06%	-30.88%	32.99%	59.94%
Enterprise Value	15,222	14,511	14,433	7,862	11,641	8,590
Last Close Price	6.06	5.81	6.78	4.05	5.89	4.36
PE Ratio	34.75	31.80	37.66	37.71	53.69	26.96
PS Ratio	4.07	3.78	4.06	2.34	3.36	2.59
PB Ratio	2.35	2.08	2.65	1.87	2.74	2.31
P/TBV Ratio	4.06	3.59	4.49	3.09	4.53	4.34
P/FCF Ratio	-	-	115.67	-	-	25.20
P/OCF Ratio	-	59.22	23.83	123.42	-	14.12
EV/Sales Ratio	4.15	3.82	3.91	2.26	3.32	2.51
EV/EBITDA Ratio	23.71	23.33	20.75	19.37	26.52	11.84
EV/EBIT Ratio	40.21	38.25	26.89	29.55	39.76	14.39
EV/FCF Ratio	-	-	111.52	-	-	24.47
Debt / Equity Ratio	0.01	0.01	0.01	0.01	0.01	0.02
Debt / EBITDA Ratio	0.13	0.13	0.11	0.14	0.12	0.08
Debt / FCF Ratio	-	-	0.60	-	-	0.16
Asset Turnover	-	0.48	0.57	-	0.65	0.68
Inventory Turnover	-	3.94	3.37	-	4.43	4.59
Quick Ratio	-	0.81	1.44	1.00	1.03	1.11
Current Ratio	-	1.42	1.98	1.67	1.76	1.52
Return on Equity (ROE)	-	9.00%	10.57%	-	6.42%	12.05%
Return on Assets (ROA)	-	3.00%	5.16%	-	3.40%	7.45%
Return on Capital (ROIC)	3.98%	3.77%	6.64%	-	4.53%	10.11%
Return on Capital Employed (ROCE)	-	5.20%	9.10%	5.90%	6.60%	14.90%
Earnings Yield	2.88%	3.15%	2.66%	2.65%	1.86%	3.71%
FCF Yield	-	-4.87%	0.86%	-3.85%	-5.18%	3.97%
Dividend Yield	0.22%	0.37%	0.33%	0.55%	-	1.71%
Payout Ratio	-	11.82%	13.89%	52.02%	64.55%	7.27%
Buyback Yield / Dilution	-14.54%	-14.54%	-4.19%	-1.57%	-2.10%	0.00%
Total Shareholder Return	-14.32%	-14.16%	-3.86%	-1.01%	-2.10%	1.71%

Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.